MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Digenic R1441G-LRRK2 and Parkin mutations in Parkinson’s Disease: first clinicopathological case report.

    D. Campo-Caballero, A. Vinagre-Aragón, JF. Martí-Massó, A. Bergareche, A. Gorostidi, R. Ruiz-Onandi, J. Rodríguez-Antigüedad, J. Equiza, P. Iruzubieta-Agudo, I. Albajar, N. Sulibarria, J. Ruiz-Martinez (San Sebastián, Spain)

    Objective: To report a clinicopathological case of digenic PD with R1441G- LRRK2 and PRKN mutations. Background: Digenic inheritance of R1441G-LRRK2 and PRKN mutation is extremely…
  • MDS Virtual Congress 2021

    SHBG, and possibly testosterone, are associated with the risk for Parkinson’s disease among women: a Mendelian randomization approach

    C. Kusters, K. Paul, A. Duarte Folle, A. Keener, J. Bronstein, L. Bertram, J. Hansen, S. Horvath, J. Sinsheimer, C. Lill, B. Ritz (Los Angeles, USA)

    Objective: To assess the association between Sex Hormone Binding Globulin (SHBG), Testosterone, and Estradiol with Parkinson's disease (PD). Background: Sex hormones may protect dopaminergic neurons,…
  • MDS Virtual Congress 2021

    Remote assessment of prodromal Parkinson’s disease in a LRRK2 G2019S cohort

    J. Soto, S. Jensen-Roberts, T. Meyers, M. Pawlik, J. Moore, A. Sarkar, R. Wilson, P. Auinger, E. Dorsey, B. Valdovinos, K. Amodeo, S. Sharma, R. Holloway, H. Rowbotham, E. Chanoff, P. Cannon, R. Alcalay, R. Schneider (Rochester, USA)

    Objective: To compare remote application of the Movement Disorder Society (MDS) prodromal Parkinson’s disease (PD) criteria to expert clinical determination of possible parkinsonism in a…
  • MDS Virtual Congress 2021

    The role of amylin in Parkinson´s disease neurodegenerative process

    R. Bugallo, I. Martínez-Valbuena, I. Marcilla, MC. Caballero, A. Vilas-Zornoza, E. Guruceaga, JA. Sánchez-Arias, S. Ursua, A. Pérez-Mediavilla, MR. Luquin (Pamplona, Spain)

    Objective: We investigate the functional interaction between two amyloidogenic (amylin and synuclein) proteins as a potential mechanism for neurodegeneration in Parkinson disease (PD). Background: PD…
  • MDS Virtual Congress 2021

    Age-dependent multisystem parkinsonian features in a novel neuromelanin-producing transgenic mouse model

    N. Peñuelas, A. Laguna, M. Gonzalez-Sepulveda, LL. Miquel-Rio, N. Benseny-Cases, H. Xicoy, J. Compte, A. Nicolau, M. Lorente-Picón, E. álvarez-Marimon, J. Romero-Giménez, A. Parent, T. Cuadros, F. Cacho-Nerin, J. Cladera, A. Bortolozzi, I. Carballo-Carbajal, M. Vila (Barcelona, Spain)

    Objective: We aim to characterize the consequences of age-dependent intracellular neuromelanin accumulation in catecholaminergic neuronal populations to understand the relationship between this process and the…
  • MDS Virtual Congress 2021

    Deep learning based detection of Parkinson’s disease (PD) in Magnetic Resonance Imaging (MRI) brain scans

    M. Courtman, L. Sun, E. Ifeachor, S. Mullin (Plymouth, United Kingdom)

    Objective: To use a deep learning based framework to classify MRI brain scans as PD or control cases. Background: The Parkinson’s Progression Markers Initiative provides…
  • MDS Virtual Congress 2021

    Tractography Analysis of the Pedunculopontine Nucleus Correlates with Gait Impairment in Parkinson’s Disease

    S. Joza, R. Camicioli, F. Ba (Edmonton, Canada)

    Objective: Our objective was to correlate pedunculopontine nucleus (PPN) connectivity with quantitative gait metrics in Parkinson’s disease (PD) using diffusion tensor imaging (DTI). Background: Gait…
  • MDS Virtual Congress 2021

    Resting state functional connectivity networks related to MDS-UPDRS motor outcomes in Parkinson’s Disease

    A. Ragothaman, M. Mancini, J. Nutt, D. Fair, O. Miranda-Dominguez, F. Horak (Portland, USA)

    Objective: Investigate the functional connectivity network pairs associated with the motor symptoms in people with Parkinson’s disease (pwPD). Background: PD is a neurodegenerative disorder primarily…
  • MDS Virtual Congress 2021

    The modification of iron accumulation in nigrosome by levodopa treatment in early Parkinson’s disease

    MD. Wang, HC. Wang, HX. Wang, J. Wang, SJ. Lu, RL. Ge, JB. Chen (Binzhou, China)

    Objective: The study was to investigate the alteration of iron accumulation in nigrosome for the early treatment of dopamine loss in PD. Background: Iron accumulation…
  • MDS Virtual Congress 2021

    The aperiodic component of cortical Local Field Potentials is affected in Parkinson’s Disease and Essential Tremor.

    A. Bush, J. Zou, W. Lipski, RM. Richardson (Boston, USA)

    Objective: Characterize the pathophysiology of Parkinson’s Disease (PD) and Essential Tremor (ET) in terms of cortical and subcortical aperiodic neural activity. Background: Classical analysis of…
  • « Previous Page
  • 1
  • …
  • 411
  • 412
  • 413
  • 414
  • 415
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley